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Aim: To investigate whether prostatic inflammation affects the contractile responses of prostate tissue and then whether melatonin has
any restorative effect on the contractile responses in a rat model of bacterial prostatitis at early stages.
Materials and methods: We evaluated the nerve-evoked, adrenergic agonist-induced or cholinergic agonist-induced contractions of
isolated prostate tissue at 24 and 72 h after intraurethrally instilled Escherichia coli-treatment. We also analyzed the histological changes
in the prostate. Secondarily, we investigated the effect of melatonin pretreatment (7 days, 10 mg kg–1 day–1) on the contractile responses
and the histopathologic changes.
Results: The degrees of acute inflammatory cell infiltration, acinar changes, and interstitial fibrosis in the prostate glands indicated the
development of acute prostatitis at 24 or 72 h after bacterial inoculation. These inflammatory changes were more pronounced at 72 h.
Bacterial prostatitis attenuated contractile responses to electrical field stimulation, phenylephrine, or carbachol. The impairment in the
contractions was more prominent at 72 h. Melatonin treatment reduced the pathologic changes and partially restored the contractile
responses at 72 h of inflammation.
Conclusion: Prostatic inflammation caused a diminution in the contractile mechanism of the prostate tissue and melatonin partially
restored the contractile responses and histopathologic changes. Melatonin can be useful as an adjuvant to the main therapies for
prostatitis to reduce the contractility problems.
Key words: Prostatitis, Escherichia coli, melatonin, smooth muscle contraction

1. Introduction
Bacterial prostatitis is a common problem in adult men
and the perineal pain seen on ejaculation with prostatitis
causes poor quality of life (1). It was suggested that the pain
of prostatitis may be due to smooth muscle contraction
(2,3). It is well known that prostatitis has an important
role in the development of benign prostatic hyperplasia
and prostate cancer (4,5).
Escherichia coli is the most common pathogen
associated with both acute and chronic bacterial cystitis
and prostatitis (6,7). Some recent papers showed that
prostatitis elicited by E. coli caused an uncontrolled growth
in the prostate gland at the early stages of inflammation
(8,9). On the other hand, in previous studies, it was shown
* Correspondence: cgocmen@cu.edu.tr

that uropathogenic E. coli or bacterial lipopolysaccharide
(LPS) treatment causes hypocontractility in various
tissues, including vessels, the urinary bladder, the corpus
cavernosum, and the vas deferens (10–14). It might thus
be expected that inflammation causes hypocontractility
in prostate tissue. Although some papers showed the
pathological and molecular features of acute prostatitis in
animal models, none showed the contractile features of the
prostate tissue (9,15,16).
The antioxidant and antiinflammatory effects of the
pineal hormone melatonin (17,18) on tissue oxidative
damage were well demonstrated in several studies on
experimental models (19–23). Additionally, in our
previous study, we showed that melatonin could prevent
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and restore the contractile impairment of the cavernous
tissue in mice treated with bacterial LPS (12).
In the present study, to clarify the above issues, we
investigated whether inflammation affects the contractile
function of the prostate tissue and whether melatonin
restores possible hypocontractility due to prostatitis in
the tissue. Thus, we planned to evaluate the nerve-evoked,
adrenergic agonist-induced or cholinergic agonist-induced
contractions of isolated rat prostate tissue to investigate
whether prostatic inflammation alters the contractile
activity at early stages. Since it has been well documented
that the intraurethral E. coli inoculation method induced
bacterial prostatitis in animals (9,15,16), we examined
the tissue responses at 24 and 72 h after intraurethrally
instilled E. coli treatment. We also analyzed the histological
changes in the prostate at 24 and 72 h after infection.
2. Materials and methods
2.1. Animals
Male Wistar albino adult rats, 3–4 months old and weighing
250–300 g (n = 50), were used throughout the experiments.
The experimental procedure was approved by the Animal
Care Committee of Çukurova University (TIBDAM;
June 2009, 6/3) and the experiments were carried out in
accordance with the Principles of Laboratory Animal Care
(National Institute of Health guideline; Publication No. 8623, revised 1984). All animals were kept under laboratory
conditions (12 h dark; 12 h light) and allowed access to
food and drink ad libitum.
2.2. Experimental groups
The rats (n = 50) were randomly divided into 4 groups: 1)
the control group (n = 20), 2) the melatonin-treated group
(n = 14), 3) the intraurethrally instilled E. coli treatment
group (E. coli-treated group; n = 16), and 4) the E. coli +
melatonin-treated group (n = 14). In the control groups,
the vehicle, saline (0.2 mL), was instilled into the prostatic
urethra of all animals (n = 16) and then the rats were
killed 24 h (n = 8) or 72 h (n = 8) after this application.
In the melatonin-treated groups, rats were treated with an
intraperitoneal melatonin (10 mg kg–1 day–1 every day at
0900 hours; n = 8) or vehicle (n = 6) for 7 days. In these
groups, saline (0.2 mL) was intraurethrally instilled on day
5 of melatonin treatment and then the animals were killed
72 h after saline inoculation on day 8. In the E. coli-treated
groups, the rats were killed 24 h (n = 8) or 72 h (n = 8)
after E. coli inoculation. In the E. coli + melatonin-treated
groups, rats (n = 14) received melatonin (10 mg kg–1)
injections for 7 days, similar to the protocol mentioned
above, and E. coli was intraurethrally instilled on day 5 of
melatonin treatment and then the animals were killed 72 h
after E. coli inoculation on day 8. The following schematic
illustrates the timing these treatments graphically.
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2.3. Drugs
Stock solutions of carbachol, phenylephrine, and KCl
were dissolved in distilled water. Melatonin was dissolved
in sterile saline. All drugs were obtained from Sigma
Chemical Co., St. Louis, MO, USA.
2.4. Preparation of bacterial suspension (E. coli)
Bacterial suspensions were prepared in a microbiology
laboratory. A strain of uropathogenic E. coli, isolated from
patients with complicated urinary tract infections, was
stored at 20 °C and grown overnight in a stock medium.
Brain heart infusion (BHI) broth with 10% sheep blood
and 10% glycerol was used as a stock medium in this
study. This medium is used for culturing of uropathogenic
strains. For inoculation to mice, we passaged strains from
this BHI stock medium to a sheep blood agar. The next day
we prepared a suspension with SF with a concentration of
McFarland 3.
2.5. Bacterial prostatitis model
The rats were anaesthetized with sevoflurane and
catheterized with a lubricated sterile polyethylene tube
(Clay Adams, PE 10). An insulin syringe was attached to the
needle and 0.2 mL of the bacterial suspension containing 9
× 108 colony-forming units/mL of E. coli was instilled into
the prostatic urethra. Anesthesia was maintained for 1 h
to prevent urinary leakage by movement of the rat and to
allow a sufficient time for bacteria to invade the prostate
(22). Animals were sacrificed at 24 or 72 h after bacterial
inoculation for in vitro prostate tissue experiments and
histopathological studies. The urine was collected before
the animals were killed for microbiological studies.
2.6. Microbiological studies
For bacterial culture, urine was passaged into Endo Agar
plates and incubated overnight at 37 °C. The colonies were
evaluated in a suspension with saline at a concentration of
McFarland 4 for uropathogenic E. coli.
2.7. Histopathological studies
Random samples of the ventral prostate from each
group were fixed in 10% formalin for 3–6 h, dehydrated,
embedded in paraffin, sectioned at 5 µm, and subsequently
stained with hematoxylin and eosin. The slides were
examined by light microscopy. The severity of prostatic
inflammation was evaluated based on 3 parameters (the
amount of chronic inflammatory cell infiltrates, acinar
changes, and interstitial fibrosis) in the representative
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area by pathologists who had no information on the
experimental group.
2.8. Measurement of prostate smooth muscle contractile
activity
Rats were killed by cervical dislocation under sevoflurane
anesthesia. After the abdominal incision, the left and
right lobes of the ventral prostate gland were removed
and placed in a petri dish containing Krebs solution
(mM: NaCl 118, KCl 4.7, CaCl2 1.5, MgCl2 1.2, NaHCO3,
NaHPO4 1.2, glucose 11). The capsules of the ventral
prostatic lobes were removed along with connective and
adipose tissues. Two preparations were obtained from
each lobe. The prostate tissues were mounted under 1 ×
g tension between 2 platinum electrodes embedded in
Perspex in 5-mL jacketed organ baths containing Krebs
solution. The organ baths maintained 37 °C and aerated
with a mixture of 95% O2 and 5% CO2. Tissues were then
allowed to equilibrate for 1 h and were washed with fresh
Krebs solution every 15 min during this period. Tissue
responses were recorded via isometric force transducer
(MAY, FDT 10-A). Data were recorded and stored using
data acquisition software (MP30, BIOPAC Systems, Inc.,
Goleta, CA, USA). After the equilibrium period, tissues
were contracted with 1) electrical field stimulation (EFS;
1, 2, 4, 8, 16, and 32 Hz; 50 V; 0.5-ms duration) delivered
from a Grass S88 stimulator (Grass Instruments, Quincy,
MA, USA) for 15 s at 1-min intervals; 2) an α1-adrenergic
receptor agonist, phenylephrine (0.1, 0.5, 1, 5, 10, 50, and
100 µM); or 3) a nonspecific cholinergic receptor agonist,
carbachol (0.1, 0.5, 1, 5, 10, 50, and 100 µM). Phenylephrine
or carbachol was added to the organ bath cumulatively.
After each treatment, tissues were washed with fresh Krebs

solution and kept for 30 min until the next application. At
the end of the experiment, tissues were contracted with
KCl (100 mM). After the contraction reached a steady
state, the tissues were washed with Krebs solution.
2.9. Statistical analysis
Changes in tension induced by EFS, phenylephrine, or
carbachol were expressed as the percentage (%) of the
maximal response to 100 mM KCl-induced contraction
at the end of each experiment. All data were expressed
as mean ± SE and were analyzed by Student’s t-test using
GraphPad Prism software (San Diego, CA, USA). P < 0.05
was considered significant.
3. Results
3.1. Microbiological data of the urine cultures
There was no bacterial growth in the urine culture obtained
from the control group. However, the urine culture showed
bacterial growth in the E. coli-treated group. No bacterial
growth was observed in melatonin + E. coli-treated rats
(data not shown).
3.2. Histopathological data of the prostate
In control animals inoculated with saline, no inflammatory
infiltrate was observed in the stroma of the ventral
prostate gland (data not shown). However, macroscopic
examination of E. coli-treated rats revealed markedly
enlarged prostates with hyperemia and edema. The degrees
of acute inflammatory cell infiltration, acinar changes,
and interstitial fibrosis in the prostate glands indicated
the development of acute prostatitis at 24 or 72 h after
bacterial inoculation (Figures 1, 2A, and 2B). There was
some infiltration by neutrophils in the stromal connective

Figure 1. Prostatic section of acute bacterial prostatitis rats, obtained 24 h after treatment. The figures show a mild-to-moderate
infiltration of acute inflammatory cells (hematoxylin and eosin, optical microscopy).
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Figure 2. Prostatic section of acute bacterial prostatitis rats, obtained 72 h after
treatment. A and B: severe infiltration by neutrophils in the stromal connective tissue
around the acini or ducts in the prostate gland obtained 72 h after E. coli treatment. C
and D: inflammatory cell infiltration and acinar changes decreased in the prostate gland
obtained from melatonin + E. coli-treated group (n = 2) (hematoxylin and eosin, optical
microscopy).

tissue around the acini or ducts in the prostate glands at
24 h after E. coli treatment (Figure 1). These inflammatory
changes were more pronounced at 72 h of infection, with
intense edema, reduction of the glandular lumen, and a
great number of inflammatory cells invading the glandular
compartment (Figures 2A and 2B). On the other hand,
in the macroscopic examination of prostate glands,
melatonin treatment significantly decreased the hyperemia
and edema at 72 h of infection. A significant reduction in
the inflammatory cell infiltration and acinar changes was
also observed at 72 h after bacterial inoculation in the
melatonin-treated group (Figures 2C and 2D).
3.3. Contractile activity in prostate smooth muscle strips
obtained from control rats
EFS (1–32 Hz) induced frequency-dependent contractions
in rat prostate smooth muscle. Phenylephrine (0.1–100
µM) or carbachol (0.1–100 µM) also contracted the
prostate smooth muscle in a concentration-dependent
manner. The contractions to these drugs were reversible
and reproducible. However, cholinergic agonist-induced
contractions were smaller compared to phenylephrineinduced contractions
3.4. Effects of E. coli treatment on contractions elicited by
EFS in prostate smooth muscle strips
The contractile responses to EFS (1–32 Hz) were
significantly decreased compared to those of controls at 24
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or 72 h after E. coli treatment (Tables 1 and 2). However,
this decrease was significant at only low frequencies (P <
0.05 at 1, 2, and 4 Hz) at 24 h (Table 1). On the other hand,
at 72 h, the impairment in the contractile responses to EFS
was more pronounced at all frequencies (P < 0.05; Table
2). Melatonin treatment (10 mg kg–1 day–1) significantly
restored the impairment in the contractions induced
by EFS of the prostate smooth muscle, except that at the
highest frequency (32 Hz) (P < 0.05; Table 2), at 72 h after
bacterial inoculation. Treatment with the melatonin alone
as used in control group did not cause any significant
alteration in the response of the tissue to EFS (data not
shown). The vehicle of melatonin used intraperitoneally
in the E. coli-treated group also had no effect (data not
shown).
3.5. Effects of E. coli treatment on contractions elicited by
phenylephrine in prostate smooth muscle strips
The contractile responses to phenylephrine were
significantly decreased compared to those of controls at 24
or 72 h after E. coli treatment (Tables 1 and 2). However,
this decrease was significant at only low frequencies (P
< 0.05 at 0.1, 0.5, and 1 µM) at 24 h (Table 1). On the
other hand, at 72 h, the impairment in the contractile
responses to phenylephrine was more pronounced at all
concentrations (P < 0.05; Table 2). Melatonin (10 mg kg–1
day–1) could significantly reverse this inhibition, except at
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Table 1. The contractile responses to electrical field stimulation (1–32 Hz, 50 V, 0.5 ms), phenylephrine (0.1–100 µM), or carbachol
(0.1–100 µM) in the prostate tissues obtained from control or E. coli-treated groups at 24 h.
Electrical field stimulation (Hz)
1

2

4

8

16

32

Control

14.0 ± 1.2

28.3 ± 2.2

49.8 ± 2.5

61.0 ± 1.5

77.3 ± 7.1

77.8 ± 3.2

E. coli

7.20 ± 0.4*

15.7 ± 2.1*

27.7 ± 3.2*

50.8 ± 4.8

58.8 ± 6.0

61.6 ± 5.6

Phenylephrine (µM)
0.1

0.5

1

5

10

50

100

Control

12.9 ± 2.1

34.9 ± 4.3

54.1 ± 6.2

83.7 ± 7.9

100.1 ± 9.9

102.8 ± 10.2

102.3 ± 8.8

E. coli

2.97 ± 0.3*

11.7 ± 3.4*

35.4 ± 3.8*

57.2 ± 7.0

69.2 ± 5.6

84.1 ± 4.5

84.9 ± 5.2

Carbachol (µM)
0.1

0.5

1

5

10

50

100

Control

8.20 ± 2.4

15.8 ± 2.9

25.5 ± 1.8

40.0 ± 4.1

48.1 ± 6.0

55.9 ± 7.6

57.4 ± 6.9

E. coli

3.22 ± 0.6*

7.3 ± 2.7

20.7 ± 1.3

29.9 ± 6.0

34.8 ± 7.2

36.9 ± 6.8

37.6 ± 9.7

Data represent the mean contractile response expressed as percentage of 100 mM KCl-induced contraction. Asterisk indicates significant
differences in contraction between E. coli-treated and control groups at P < 0.05.
Table 2. The contractile responses to electrical field stimulation (1–32 Hz, 50 V, 0.5 ms), phenylephrine (0.1–100 µM), or carbachol
(0.1–100 µM) in the prostate tissues obtained from control, E. coli-treated, or E. coli + melatonin-treated (E. coli-M) groups at 72 h.
Electrical field stimulation (Hz)
1

2

4

8

16

32

Control

31.8 ± 1.6

50.2 ± 2.3

81.0 ± 5.8

120.5 ± 11.0

141.1 ± 11.5

153.0 ± 10.4

E. coli

19.8 ± 2.5*

32.6 ± 3.3*

44.4 ± 6.6*

51.4 ± 8.5*

59.2 ± 8.1*

67.6 ± 10.4*

E. coli-M

33.5 ± 2.3+

50.0 ± 5.1+

73.5 ± 5.0+

85.5 ± 4.6+

96.5 ± 2.5+

108.7 ± 5.9+

Phenylephrine (µM)
0.1

0.5

1

5

10

50

100

Control

10.9 ± 1.9

37.2 ± 4.4

61.5 ± 6.6

91.8 ± 8.6

130 ± 11

150 ± 20

146 ± 14

E. coli

5.6 ± 0.8*

16.8 ± 2.6*

41.0 ± 3.7*

50.7 ± 5.8*

62.8 ± 2.9*

76.5 ± 9.6*

78.8 ± 9.2*

E. coli-M

14.2 ± 1.8

41.8 ± 3.2

59.0 ± 3.3

77.3 ± 2.3

88.3 ± 3.9

95.8 ± 5.9

101 ± 7.0+

+

+

+

+

+

+

Carbachol (µM)
0.1

0.5

1

5

10

50

100

Control

12.0 ± 2.9

18.4 ± 3.5

30.0 ± 5.6

50.8 ± 12

62.2 ± 13

68.8 ± 12

69.7 ± 11

E. coli

3.6 ± 0.0*

11.9 ± 4.8

20.3 ± 5.1

27.4 ± 8.3

32.1 ± 8.9

36.9 ± 8.5

40.5 ± 7.2

E. coli-M

5.0 ± 0.7

12.3 ± 2.3

16.3 ± 2.9

30.0 ± 5.6

38.8 ± 7.3

42.5 ± 7.3

46.9 ± 8.0

Data represent the mean contractile response expressed as percentage of 100 mM KCl-induced contraction. Asterisk indicates significant
differences in contraction between E. coli-treated and control groups at P < 0.05. (+) indicates significant differences in contraction
between E. coli-treated and E. coli-M groups for each column at P < 0.05.
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high concentrations (50 and 100 µM) of phenylephrine,
at 72 h after bacterial inoculation (Table 2). Treatment
with the melatonin alone used in the control group did
not cause any significant alteration in the response of the
tissue to phenylephrine (data not shown). The vehicle of
melatonin used intraperitoneally in the E. coli-treated
group also had no effect (data not shown).
3.6. Effects of E. coli treatment on contractions elicited by
carbachol in prostate smooth muscle strips
E. coli treatment caused some decrease in the contractile
response of the tissue to carbachol at 24 or 72 h after E.
coli treatment, but a significant impairment was observed
at only the lowest concentration of carbachol at 72 h after
bacterial inoculation (P < 0.05 at 0.1 µM; Tables 1 and 2).
Melatonin (10 mg kg–1 day–1) could reverse this inhibition
(Table 2). Treatment with the melatonin alone used in the
control group did not cause any significant alteration in
the response of the tissue to carbachol (data not shown).
The vehicle of melatonin used intraperitoneally in the E.
coli-treated group also had no effect (data not shown).
4. Discussion
The major finding of the present study was that the bacterial
prostatic inflammation elicited by intraurethrally instilled
E. coli affected contractile activity of the rat prostate tissue
at early stages. Prostatitis caused a marked impairment in
the contractile activity induced by EFS, phenylephrine, or
carbachol in rat prostate tissue at 24 or 72 h after E. coli
treatment. Treatment with melatonin partially prevented
the impairment in EFS-, phenylephrine-, or carbacholinduced contractile responses of the prostate gland in
prostatitis rat. Melatonin treatment also significantly
reduced the inflammatory cell infiltration and acinar
changes at 72 h after bacterial inoculation.
In the present study, intraurethrally instilled E. coli
caused acute inflammatory cell infiltration, acinar changes,
and interstitial fibrosis in the prostate glands at 24 or 72 h
after bacterial inoculation. These histopathologic features
at early stages indicated development of an acute bacterial
prostatic inflammation. These inflammatory changes were
more pronounced at 72 h of infection, with intense edema,
reduction of the glandular lumen, and a great number of
inflammatory cells invading the glandular compartment.
Our histopathologic findings were consistent with those of
previous studies (9,15,16).
Bacterial prostatitis also significantly attenuated
contractile responses of the prostate gland to electrical
field stimulation (EFS), phenylephrine, or carbachol
compared to those of control group. However, the
impairment in the contractions was more prominent at 72
h of prostatic inflammation. This finding suggests that the
impairment in the contractile mechanism of the tissue may
be associated with the degree of prostatic inflammation
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since there was a severe infiltration in the prostate glands
at 72 h after bacterial inoculation. This impairment of
the contractile activity may be due to various reasons. It
was shown that prostatic inflammation, even at the early
stages, causes a dedifferentiation of smooth muscle cells
(9). It was suggested in the same study that prostatic
smooth muscle cells become secretory cells in response
to E. coli. Additionally, Leimgruber et al. described a
dedifferentiation process of smooth muscle cells after
bacterial LPS treatment, with a loss of cytoskeleton
molecules that characterized contractile phenotype (8).
In another recent study, it was shown that inflammation
caused the loss of smooth muscle cells around prostate
ducts (24). Although we could not comprehensively
examine the smooth muscles by light microscopy, it can
be suggested that E. coli treatment affected the smooth
muscles in the prostate gland in light of these papers.
However, some previous studies suggested that
inflammation induced by uropathogenic E. coli or bacterial
LPS alters the contractile mechanism of the tissues via
production of free radicals and/or lipid peroxidation caused
by the inducible nitric oxide synthase (iNOS)-related
pathway (12,25–27). Therefore, it is possible that increased
oxidative products due to prostatic inflammation induced
by intraurethral E. coli application cause an impairment in
the contractile mechanism of the prostate tissue. However,
we need further experiments, such as studies of iNOS
expression, to explain the impairment of the contractions
with prostatic inflammation.
Interestingly, in some clinical studies with patients,
the pain is thought to be due to prolonged smooth muscle
contraction caused by α1-adrenoceptor activation in the
prostate (2,3,28). In these papers, it was suggested that
α1-adrenoceptor blockers might be useful, possibly by
promoting smooth muscle relaxation in the treatment
of prostatic pain. However, our findings indicate that
bacterial inflammation causes a decrease in the contractile
activity of the prostate gland. Thus, the beneficial effect of
α1-adrenoceptor blockers on the pain may be due to other
mechanism(s) in prostatitis.
On the other hand, the impairment of the carbacholinduced contractions was less pronounced in the prostate
tissue after E. coli treatment. However, cholinergic
agonist-induced contractions were smaller compared to
adrenergic agonist-induced contractions. Since it was
shown that the contractile response to cholinomimetic
agents such as acetylcholine or carbachol was less than
that to adrenoceptor agonists (29), the contractions to
carbachol might be less affected by prostatic inflammation.
In the present study, histopathologic results showed
that melatonin treatment was partially effective to prevent
severe infiltration in the prostate glands. Melatonin
could also reverse the impairment of the neurogenic
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and adrenergic contractions of prostate tissue. Beneficial
effects of the pineal hormone melatonin on tissue
oxidative damage have been demonstrated in studies on
experimental models. In these studies, it was shown that
melatonin has highly potent free radical scavenging ability
and it was suggested that this action may contribute to
the antiinflammatory effects of this agent (12,19–23).
However, this possible mechanism must be supported by
measuring antioxidant enzyme activities.
In conclusion, prostatitis caused a marked impairment
in the neurogenic and adrenergic contractile activity
in the rat prostate tissue. A possible dedifferentiation of
smooth muscle cells and increased oxidative activity in the

prostate tissue may be major reasons for the diminution
in contractile mechanism. Treatment with melatonin
prevented the impairment of the contractile responses and
histopathologic changes due to prostatic inflammation.
Melatonin can be useful as an adjuvant to the main therapies
for prostatitis to reduce the contractility problems.
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